Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 92 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $856,642 | -19.7% | 157,182 | 0.0% | 0.08% | -33.6% |
| Q2 2023 | $1,067,266 | +144.3% | 157,182 | +80.3% | 0.12% | +164.4% |
| Q1 2023 | $436,782 | +2.7% | 87,182 | 0.0% | 0.04% | -26.2% |
| Q4 2022 | $425,448 | -66.2% | 87,182 | 0.0% | 0.06% | -64.3% |
| Q3 2022 | $1,257,000 | -39.0% | 87,182 | -36.0% | 0.17% | -46.7% |
| Q2 2022 | $2,060,000 | -27.4% | 136,182 | -43.0% | 0.32% | -12.3% |
| Q1 2022 | $2,839,000 | -43.6% | 238,982 | -23.0% | 0.37% | -27.4% |
| Q4 2021 | $5,033,000 | -33.6% | 310,494 | +16.9% | 0.50% | -57.4% |
| Q3 2021 | $7,583,000 | +55.5% | 265,700 | +84.1% | 1.18% | +57.6% |
| Q2 2021 | $4,877,000 | – | 144,300 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |